This finding corroborates earlier evidence from Annibalini et al. [30] that indicated significant increases in IGF-1 after CT in middle-aged patients with type 2 diabetes (p < 0.05) compared to controls. The gene discussed is IGF1; the disease is type 2 diabetes mellitus.